MedPath

AMPROLOX 20% w/w POWDER

Registration Number: MAL24026026HA

Approved
Approval ID

c7f45ed2fa9f827e

Registration Number

MAL24026026HA

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types4 types
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (4)

100 gmAvailable
Package Size: 100 gm
Status: NPRA Approved
200 gmAvailable
Package Size: 200 gm
Status: NPRA Approved
500 gmAvailable
Package Size: 500 gm
Status: NPRA Approved
1 kgAvailable
Package Size: 1 kg
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (1)

AMPROLIUM HYDROCHLORIDEActive
Monograph: amprolium hydrochloride

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

AMPROLOX 20% w/w POWDER - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform